Home›Research›Compare›Liraglutide vs Pramlintide
Peptide ComparisonLiraglutide vs Pramlintide
Both are Metabolic peptides.
Liraglutide
Victoza
Half-life: 13 hours
51 providers listed
Pramlintide
Symlin
Half-life: ~48 minutes
No providers listed yet
Liraglutide carries stronger published evidence (RCT, 15 key studies) than Pramlintide (RCT, 4); both are research compounds.
Liraglutide
Evidence
Half-life
13 hours
Pramlintide
Evidence
Half-life
~48 minutes
| Your goal | Better option |
|---|---|
| Stronger clinical evidence | Liraglutide |
| Less frequent dosing (longer half-life) | Liraglutide |
| More provider options (51 vs 0) | Liraglutide |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
Liraglutide
Pramlintide
Liraglutide
Semaglutide vs liraglutide for weight loss in adults with overweight or obesity
A randomized, controlled trial of 3.0 mg of liraglutide in weight management
Comparative Effects of Individual Glucagon-Like Peptide-1 Receptor Agonist-Based Medications on Direct Measur…
GLP-1 receptor agonists in pediatric obesity and diabetes: a systematic review of efficacy, metabolic effects…
+11 more
Pramlintide
Pramlintide reduced 24-h caloric intake and increased satiety in obese subjects: a randomized, double-blind,…
In vitro metabolic profiling of weight-loss-inducing amylin receptor agonists in the context of preventive do…
Pramlintide combined with metreleptin in obesity: sustained reductions in weight, metabolic markers, and lept…
Pramlintide.
About Liraglutide
GLP-1 receptor agonist; slows gastric emptying, increases satiety, reduces glucagon secretion
About Pramlintide
Synthetic amylin analogue; activates amylin receptors in hypothalamus; slows gastric emptying, suppresses glucagon, enhances satiety
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
Liraglutide
Risk of thyroid C-cell tumors (dose- and duration-dependent in rodents; human relevance undetermined).
Source: FDA label
Under clinical review
Being verified by our medical team before we display monitoring guidance for this peptide.
Pramlintide
No established clinical contraindications
Under clinical review
Being verified by our medical team before we display monitoring guidance for this peptide.
Where to source these peptides
Liraglutide
51 listed
Browse directory →
Providers offeringPramlintide
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More Metabolic Comparisons
Browse all peptides →Educational research tools — not medical advice.